Improving imaging techniques to monitor immune responses in bone cancer treatment
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
This study is looking at new ways to see how well cancer treatments, especially immunotherapies, are working by tracking certain immune cells in bone tumors, which could help doctors find better treatment options for patients with osteosarcoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10899555 on NIH RePORTER |
What this research studies
This research focuses on developing advanced imaging methods to track how tumors respond to new cancer therapies, particularly immunotherapies. By optimizing techniques to visualize tumor-associated macrophages in osteosarcomas, the study aims to provide better tools for assessing treatment effectiveness. The approach involves both preclinical and clinical phases, utilizing quantitative imaging to enhance the understanding of immune responses in cancer. This could lead to more effective treatment strategies for patients with bone sarcomas.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with osteosarcoma who are undergoing or considering immunotherapy treatments.
Not a fit: Patients with cancers other than osteosarcoma or those not receiving immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring of treatment responses in patients with bone cancer, potentially enhancing therapeutic outcomes.
How similar studies have performed: Previous research has shown promise in using imaging techniques to monitor immune responses in cancer, indicating that this approach has potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Daldrup-Link, Heike Elizabeth — Stanford University
- Study coordinator: Daldrup-Link, Heike Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.